{
    "2021-01-26": [
        [
            {
                "time": "",
                "original_text": "百克生物科创板IPO：产品商业化相对单薄 体外培育另一手准备 能否支撑上市后估值？",
                "features": {
                    "keywords": [
                        "百克生物",
                        "科创板",
                        "IPO",
                        "产品商业化",
                        "体外培育"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-02-01",
                "original_text": "国内水痘疫苗龙头百克生物2月1日上会 科创板16.81亿元募资能否带来新方向？",
                "features": {
                    "keywords": [
                        "百克生物",
                        "水痘疫苗",
                        "科创板",
                        "募资"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗健康行业基金4Q分析：四季度医药板块配置环比下降 机构持仓名进一步集中",
                "features": {
                    "keywords": [
                        "医疗健康",
                        "基金",
                        "医药板块",
                        "配置下降",
                        "机构持仓"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药周报：疫情防控需求带来业绩弹性 精选优质检测标的",
                "features": {
                    "keywords": [
                        "医药",
                        "疫情防控",
                        "业绩弹性",
                        "检测标的"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-23",
                "original_text": "【山证医药】医药行业周报（20210123）：业绩预告密集发布，持续关注高景气细分领域",
                "features": {
                    "keywords": [
                        "医药行业",
                        "业绩预告",
                        "高景气",
                        "细分领域"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "长春高新拆分百克生物拟冲科创板 停产狂犬疫苗研发多靠\"体外\" 经营问题",
                "features": {
                    "keywords": [
                        "长春高新",
                        "百克生物",
                        "科创板",
                        "狂犬疫苗",
                        "经营问题"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "中信建投五大研究团队复盘2020年四季度公募基金持仓",
                "features": {
                    "keywords": [
                        "中信建投",
                        "公募基金",
                        "持仓",
                        "复盘"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}